Nexalin Technology (NXL) Accumulated Expenses (2021 - 2026)

Nexalin Technology's Accumulated Expenses history runs 6 years deep, the most recent figure standing at $640265.0 for Q1 2026.

• On a quarterly basis, Accumulated Expenses rose 62.78% year-over-year to $640265.0 in Q1 2026; TTM through Mar 2026 was $640265.0, a 62.78% increase from a year earlier, with the FY2025 full-year figure at $642754.0, up 64.49% from the prior year.
• Accumulated Expenses steadied at $640265.0 in Q1 2026 per NXL's latest filing, from $642754.0 in the prior quarter.
• Across five years, Accumulated Expenses topped out at $642754.0 in Q4 2025 and bottomed at $124966.0 in Q2 2024.
• The 5-year median for Accumulated Expenses is $393342.0 (2025), against an average of $425497.2.
• Across the five-year window, Accumulated Expenses sank 79.3% in 2024 and soared 188.08% in 2025, its largest moves.
• Year by year, Accumulated Expenses stood at $539822.0 in 2022, then slumped by 51.6% to $261284.0 in 2023, then jumped by 49.55% to $390745.0 in 2024, then jumped by 64.49% to $642754.0 in 2025, then retreated by 0.39% to $640265.0 in 2026.
• Per Business Quant, the three latest NXL Accumulated Expenses figures stand at $640265.0 (Q1 2026), $642754.0 (Q4 2025), and $290031.0 (Q3 2025).